In a market where it’s tough to find value, healthcare business Healius (ASX:HLS) could be the next company to outperform.
The blue chips in the ASX top 10 have proved to be resilient, even despite this week’s sell-off. But apart from CSL, their share prices have barely budged.
The stock market has been a rollercoaster ride over the last few weeks, but Experience Co shareholders have been on an adventure-filled ride for years.
Watch out if you want income from health care or technology shares. The Australian sharemarket is one of the highest dividend payers in the world but not all sectors are equal where dividends are concerned.
Ross McEwan will take over as NAB CEO no later than April 2020, but it’s difficult to see how he can change the bank’s profitability problems.
The US remains the world’s largest medical device market with no signs of slowing, and Boston Scientific is at the forefront of the ultra-competitive industry.
While miners led the corporate reporting season, which is currently underway in Australia, what can we expect across the broader market?
A growing focus on the medicinal benefits of cannabis-derived drugs could spark up the industry as demand for cannabis stocks soars.